Virus de l'immunodéficience humaine : cycle viral et épidémiologie ,
, , 2018.
Virus de l'immunodéficience humaine, 2011. ,
, Prise en charge du VIH -Recommandations du groupe d'experts, 2018.
Diabetes mellitus in HIV-infected patients: fasting glucose, A1c, or oral glucose tolerance test -which method to choose for the diagnosis?, BMC Infect Dis, vol.18, issue.1, p.309, 2018. ,
, With Special Feature on Prescription Drugs, 2013.
,
, IDF Diabetes Atlas, 2018.
, , 2018.
Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence, Popul Health Metr, vol.8, p.29, 2010. ,
Insulin resistance is not necessarily an essential component of type 2 diabetes, J Clin Endocrinol Metab, vol.85, issue.6, pp.2113-2118, 2000. ,
Prevalence of type 2 diabetes mellitus in elderly in a primary care facility: An ideal facility, Indian J Endocrinol Metab, vol.17, issue.Suppl1, pp.318-340, 2013. ,
Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study, Arch Intern Med, vol.165, issue.10, pp.1179-84, 2005. ,
Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy, Eur J Epidemiol, vol.27, issue.8, pp.657-65, 2012. ,
Diabetes trends in hospitalized HIV-infected persons in the United States, Curr HIV Res, vol.7, issue.5, pp.481-487, 1994. ,
search?client=safari&rls=en&q=Friis-M%C3%B8ller+N,+Sabin+CA,+Weber+R,+d%27Arminio+Monforte+A,+El-Sadr+WM,+Reiss+P,+Thi%C3%A9baut+R,+Morfeldt+L,+De+Wit+S,+Pradier+C,+Calvo+G ,+Law+MG,+Kirk+O,+Phillips+AN,+Lundgren+JD, N Engl J Med, vol.349, issue.21, pp.1993-2003, 2003. ,
Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study), Circulation, vol.119, issue.6, pp.805-816, 2009. ,
Cardiovascular risk and body-fat abnormalities in HIV-infected adults, N Engl J Med, vol.352, issue.1, pp.48-62, 2005. ,
Prevalence and pathogenesis of diabetes mellitus in HIV-1 infection treated with combined antiretroviral therapy, J Acquir Immune Defic Syndr, vol.50, issue.5, pp.499-505, 1999. ,
Diabetes mellitus type 2 and abnormal glucose metabolism in the setting of human immunodeficiency virus, Endocrinol Metab Clin North Am, vol.43, issue.3, pp.685-96, 2014. ,
Les lipodystrophies secondaires aux traitements antirétroviraux de l'infection par le VIH, MS Médecine Sci, vol.22, issue.5, pp.531-537, 2006. ,
Understanding the complications of antiretroviral drugs, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.47, issue.4, pp.575-581, 2008. ,
HIV infection, inflammation, immunosenescence, and aging, Annu Rev Med, vol.62, pp.141-55, 2011. ,
Inflammatory and coagulation biomarkers and mortality in patients with HIV infection, PLoS Med, vol.5, issue.10, p.203, 2008. ,
Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy, Diabetes Care, vol.33, issue.10, pp.2244-2253, 2010. ,
, Actualisation 2015 du rapport Morlat | Corevih IDF Nord, 2018.
Incidence of diabetes mellitus in a population-based cohort of HIV-infected and non-HIV-infected persons: the impact of clinical and therapeutic factors over time, Diabet Med J Br Diabet Assoc, vol.31, issue.10, pp.1185-93, 2014. ,
, Haute Autorité de Santé -Prévention et dépistage diabète de type 2 & maladies liées au diabète, 2018.
Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention ,
, World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity, American Heart Association, vol.120, issue.16, pp.1640-1645, 2009.
, Les chiffres du diabète en France | Fédération Française des Diabétiques, 2018.
Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009-2010, BMJ Open Diabetes Res Care, vol.5, issue.1, p.304, 2017. ,
Risk of Diabetes Mellitus in Persons with and without HIV: A Danish Nationwide Population-Based Cohort Study, PLOS ONE, vol.7, issue.9, p.44575, 2012. ,
Prevalence of and risk factors for prediabetes in HIV-1-infected patients in, J Int Assoc Physicians AIDS Care Chic Ill, vol.9, issue.6, pp.358-61, 2002. ,
Prevalence of and Risk Factors for Prediabetes in Patients Infected With HIV, Diabetes Spectr, vol.31, issue.2, pp.139-182, 2018. ,
, , 2018.
Metabolic syndrome, diabetes, and cardiovascular risk in HIV, Curr HIV/AIDS Rep, vol.11, issue.3, pp.271-279, 2014. ,
Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy, Circulation, vol.118, issue.2, pp.29-35, 2008. ,
The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials, BMC Infect Dis, vol.10, p.183, 2010. ,
The effects of HIV protease inhibitors atazanavir and lopinavir/ritonavir on insulin sensitivity in HIV-seronegative healthy adults, AIDS Lond Engl, vol.18, issue.16, pp.2137-2181, 2004. ,
Impact of Randomized Antiretroviral Therapy Initiation on Glucose Metabolism: AIDS Clinical Trials Group Study A5224s, AIDS Lond Engl, vol.28, issue.10, pp.1451-61, 2014. ,
CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy, AIDS Lond Engl [Internet], vol.25, issue.14, 2011. ,
VIH, lipodystrophies et troubles métaboliques, Sang Thromb Vaiss, vol.15, issue.9, pp.487-98, 2003. ,
Long-term glucose tolerance in highly experienced HIV-infected patients receiving nucleoside analogue-sparing regimens, AIDS Lond Engl, vol.26, issue.14, pp.1837-1877, 2012. ,